Polaris Venture Partners Founders' Fund V, L.P., 10% Owner at OCULAR THERAPEUTIX, INC (OCUL), sold 500,000 shares at $29.50 ($14.8M) on 2015-02-02, disclosed to the SEC on 2015-02-04.
Open-market sale of $14.8M OCUL by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.50 | 3,304 | $97K | 0.7% |
| 2 | $29.50 | 4,824 | $142K | 1.0% |
| 3 | $29.50 | 9,403 | $277K | 1.9% |
| 4 | $29.50 | 482,469 | $14.2M | 96.5% |
| Total | $29.50 avg | 500,000 | $14.8M | 100% |
| Filing → |
| TTOO | SELL | 2015-07-07 | $716K | — | Filing → |
| TTOO | SELL | 2015-06-24 | $546K | — | Filing → |
| CERU | BUY | 2014-04-15 | $10.3M | — | Filing → |